{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:13:13Z","timestamp":1790255593191,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T00:00:00Z","timestamp":1729728000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R61\/R33DA057683"],"award-info":[{"award-number":["R61\/R33DA057683"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.josat.2024.209547","type":"journal-article","created":{"date-parts":[[2024,10,20]],"date-time":"2024-10-20T14:21:01Z","timestamp":1729434061000},"page":"209547","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Payment and billing strategies to support methadone take-home medication: Perspectives of financial leaders of opioid treatment program organizations in New York State"],"prefix":"10.1016","volume":"168","author":[{"given":"Yuhua","family":"Bao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan A.","family":"O'Grady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayla","family":"Hutchings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju-Chen","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Knopf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shazia","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley","family":"Puryear","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pat","family":"Lincourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashly E.","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles J.","family":"Neighbors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.josat.2024.209547_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108552","article-title":"Changes in methadone take-home dosing before and after COVID-19","volume":"133","author":"Amram","year":"2022","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"3","key":"10.1016\/j.josat.2024.209547_bb0010","first-page":"597","article-title":"The place of inter-rater reliability in qualitative research: An empirical study","volume":"31","author":"Armstrong","year":"1997","journal-title":"Sociology - the Journal of the British Sociological Association"},{"issue":"5","key":"10.1016\/j.josat.2024.209547_bb0015","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1007\/s10488-015-0673-6","article-title":"A prospective examination of clinician and supervisor turnover within the context of implementation of evidence-based practices in a publicly-funded mental health system","volume":"43","author":"Beidas","year":"2016","journal-title":"Administration and Policy in Mental Health"},{"issue":"4","key":"10.1016\/j.josat.2024.209547_bb0020","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1111\/j.1475-6773.2006.00684.x","article-title":"Qualitative data analysis for health services research: Developing taxonomy, themes, and theory","volume":"42","author":"Bradley","year":"2007","journal-title":"Health Services Research"},{"key":"10.1016\/j.josat.2024.209547_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108449","article-title":"Changes in methadone program practices and fatal methadone overdose rates in Connecticut during COVID-19","volume":"131","author":"Brothers","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2024.209547_bb0030","author":"Centers for Medicare & Medicaid Services"},{"issue":"6","key":"10.1016\/j.josat.2024.209547_bb0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0286859","article-title":"Clinics Optimizing MEthadone Take-homes for opioid use disorder (COMET): Protocol for a stepped-wedge randomized trial to facilitate clinic level changes","volume":"18","author":"Choi","year":"2023","journal-title":"Plos One"},{"issue":"1","key":"10.1016\/j.josat.2024.209547_bb0040","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13011-022-00478-y","article-title":"Medicaid professional fees for treatment of opioid use disorder varied widely across states and were substantially below fees paid by medicare in 2021","volume":"17","author":"Clemans-Cope","year":"2022","journal-title":"Substance Abuse Treatment, Prevention, and Policy"},{"issue":"1","key":"10.1016\/j.josat.2024.209547_bb0045","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13012-021-01182-4","article-title":"Translating Medicaid policy into practice: Policy implementation strategies from three US states\u2019 experiences enhancing substance use disorder treatment","volume":"17","author":"Crable","year":"2022","journal-title":"Implementation Science"},{"issue":"1","key":"10.1016\/j.josat.2024.209547_bb0050","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13012-022-01256-x","article-title":"Where is \u201cpolicy\u201d in dissemination and implementation science? Recommendations to advance theories, models, and frameworks: EPIS as a case example","volume":"17","author":"Crable","year":"2022","journal-title":"Implementation Science"},{"issue":"1","key":"10.1016\/j.josat.2024.209547_bb0055","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s43058-023-00492-6","article-title":"Who\u2019s \u201cin the room where it happens\u201d? A taxonomy and five-step methodology for identifying and characterizing policy actors","volume":"4","author":"Cruden","year":"2023","journal-title":"Implementation Science Communications"},{"key":"10.1016\/j.josat.2024.209547_bb0060","doi-asserted-by":"crossref","DOI":"10.1177\/2633489520939980","article-title":"A scoping review of strategies for financing the implementation of evidence-based practices in behavioral health systems: State of the literature and future directions","volume":"1","author":"Dopp","year":"2020","journal-title":"Implementation Research and Practice"},{"issue":"1","key":"10.1016\/j.josat.2024.209547_bb5000","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13012-023-01305-z","article-title":"Comparing organization-focused and state-focused financing strategies on provider-level reach of a youth substance use treatment model: a mixed-method study","volume":"18","author":"Dopp","year":"2023","journal-title":"Implementation Science"},{"key":"10.1016\/j.josat.2024.209547_bb0065","author":"Federal Register: Medications for the Treatment of Opioid Use Disorder"},{"key":"10.1016\/j.josat.2024.209547_bb0070","article-title":"State guidance and system changes related to COVID-19: Impact on opioid treatment programs","volume":"158","author":"Fuller","year":"2023","journal-title":"Journal of Substance Use and Addiction Treatment"},{"key":"10.1016\/j.josat.2024.209547_bb0075","series-title":"The discovery of grounded theory: Strategies for qualitative research","first-page":"282","author":"Glaser","year":"2000"},{"issue":"2","key":"10.1016\/j.josat.2024.209547_bb0080","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1037\/0022-0167.52.2.196","article-title":"Consensual qualitative research: An update","volume":"52","author":"Hill","year":"2005","journal-title":"Journal of Counseling Psychology"},{"key":"10.1016\/j.josat.2024.209547_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108288","article-title":"Clinician perspectives on methadone service delivery and the use of telemedicine during the COVID-19 pandemic: A qualitative study","volume":"124","author":"Hunter","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2024.209547_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2024.111283","article-title":"Methadone dosing at New York State opioid treatment programs following initial revisions to federal regulations","volume":"258","author":"Jordan","year":"2024","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2024.209547_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2020.108219","article-title":"Reimagining patient-centered care in opioid treatment programs: Lessons from the Bronx during COVID-19","volume":"122","author":"Joseph","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"3","key":"10.1016\/j.josat.2024.209547_bb0100","doi-asserted-by":"crossref","first-page":"e238","DOI":"10.1016\/S2468-2667(23)00023-3","article-title":"Synthesising evidence of the effects of COVID-19 regulatory changes on methadone treatment for opioid use disorder: Implications for policy","volume":"8","author":"Krawczyk","year":"2023","journal-title":"The Lancet. Public Health"},{"issue":"1","key":"10.1016\/j.josat.2024.209547_bb0105","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s13012-017-0657-x","article-title":"Beyond \u201cimplementation strategies\u201d: Classifying the full range of strategies used in implementation science and practice","volume":"12","author":"Leeman","year":"2017","journal-title":"Implementation Science"},{"key":"10.1016\/j.josat.2024.209547_bb0110","series-title":"Medicaid Billing Guidance for NYS Opioid Treatment Programs (OTPs) Programs Operating During the COVID-19 Emergency \u2013 Beginning March 16, 2020","author":"OASAS","year":"2020"},{"key":"10.1016\/j.josat.2024.209547_bb0115","series-title":"Medicaid Billing Guidance for NYS Opioid Treatment Programs (OTPs) Programs Operating During the COVID-19 Emergency \u2013 Beginning March 16, 2020 (Revised Guidance \u2013 3\/15\/21 \u2013 Revisions Highlighted in Red)","author":"OASAS","year":"2021"},{"key":"10.1016\/j.josat.2024.209547_bb0120","series-title":"OASAS OTP Bundle Billing Guidance September 2023","author":"OASAS","year":"2023"},{"key":"10.1016\/j.josat.2024.209547_bb0125","series-title":"OASAS OTP Bundle Billing Guidance March 2024","author":"OASAS","year":"2024"},{"key":"10.1016\/j.josat.2024.209547_bb0130","article-title":"How are substance use disorder treatment programs adjusting to value-based payment? A statewide qualitative study","volume":"14","author":"O\u2019Grady","year":"2020","journal-title":"Substance Abuse: Research and Treatment"},{"key":"10.1016\/j.josat.2024.209547_bb0135","doi-asserted-by":"crossref","DOI":"10.1177\/26334895221135265","article-title":"Together in care: Lessons learned at the intersection of integrated care, quality improvement, and implementation practice in opioid treatment programs","volume":"3","author":"O\u2019Grady","year":"2022","journal-title":"Implementation Research and Practice"},{"key":"10.1016\/j.josat.2024.209547_bb0140","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13012-015-0209-1","article-title":"A refined compilation of implementation strategies: Results from the Expert Recommendations for Implementing Change (ERIC) project","volume":"10","author":"Powell","year":"2015","journal-title":"Implementation Science"},{"issue":"8","key":"10.1016\/j.josat.2024.209547_bb0145","doi-asserted-by":"crossref","DOI":"10.1001\/jamahealthforum.2023.2502","article-title":"Changes in medicaid fee-for-service benefit design for substance use disorder treatment during the opioid crisis, 2014 to 2021","volume":"4","author":"Shoulders","year":"2023","journal-title":"JAMA Health Forum"},{"key":"10.1016\/j.josat.2024.209547_bb0150","series-title":"Federal guidelines for opioid treatment programs","author":"Substance Abuse and Mental Health Services Administration","year":"2015"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875924002595?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875924002595?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T06:19:07Z","timestamp":1733293147000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875924002595"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":31,"alternative-id":["S2949875924002595"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2024.209547","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Payment and billing strategies to support methadone take-home medication: Perspectives of financial leaders of opioid treatment program organizations in New York State","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2024.209547","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"209547"}}